Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial on Comprehensive Exercise-based Cardiac Rehabilitation Programs for the Prevention of Anthracyclines and/or Anti-HER2 Antibodies-induced Cardiotoxicity in Breast Cancer

NCT03964142 is registered in ClinicalTrials.gov with Hospital Clinico Universitario de Santiago as lead sponsor.

NCT NCT03964142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03964142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial on Comprehensive Exercise-based Cardiac Rehabilitation Programs for the Prevention of Anthracyclines and/or Anti-HER2 Antibodies-induced Cardiotoxicity in Breast Cancer
Lead sponsor
Hospital Clinico Universitario de Santiago
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2018
Completion date
January 1, 2023
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac rehabilitation, cardiotoxicity